View All In Series
Published on December 22, 2020
Experts Share Research Developments, News from Clinical Trials
What emerging therapies and research findings for acute lymphoblastic leukemia (ALL) were discussed at ASH 2020? How are doctors mitigating long-term side effects for children with ALL? What are doctors learning at diagnosis that can steer treatment options? Are clinical trials paving the way to new treatments and better outcomes?
Hear three of the world's leading acute lymphoblastic leukemia experts answer these important questions on the status of ALL patient care. In this segment, Patient Power staff writer Lauren Evoy Davis hosts Dr. Patrick Brown, MD, of Johns Hopkins Medicine, Dr. Hetty Carraway, MD, of the Cleveland Clinic and Dr. Kavitha Ramaswamy, MD, of Memorial Sloan Kettering Cancer Center. They will also share the questions patients should be asking their healthcare providers to ensure the highest quality of care.
This program is sponsored by Amgen. This organization has no editorial control. It is produced by Patient Power, and Patient Power is solely responsible for program content.
Recommended for You: